UTHR News and Press, United Therapeutics Corporation From 02/08/23

Summary The market has swiftly priced in United Therapeutics Corporation's patent dispute. The company exhibits strong profitability momentum, with growth coming in at a low cost to earnings. It, therefore, feeds a high percentages of residual free cash flows to shareholders. Ne...

The following slide deck was published by United Therapeutics Corporation in conjunction with this event. For further details see: United Therapeutics (UTHR) Presents At 41st Annual Healthcare Conference - Slideshow

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech stocks are in high demand right now, with good reason. Indeed, these biotech companies have the potential to revolutionize the medical world and offer solutions to unmet needs, while their relevance is recession-proof. ...

United Therapeutics Corporation (Nasdaq: UTHR ) announced today that Dr. Martine Rothblatt , Chairperson and Chief Executive Officer, will provide an overview and update on the company’s business during a fireside chat session at the 41 st annual J.P. Morgan Healthcare Conferen...

Summary Today, we take our first look at a biopharma concern called Liquidia Corporation. The company has a potential 'best of breed' product whose launch has been held up due to litigation challenges. Is the stock a buy for patient investors? An investment analysis follows in ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips If there’s a silver lining regarding the coronavirus pandemic, it’s that it demonstrated the importance of the top biotech stock picks for 2023. While medical innovations may seem frustratingly slow, the Covid-19 ...

Summary Gossamer Bio, Inc.'s lead candidate - Seralutinib, indicated for Pulmonary Arterial Hypertension - met its primary endpoint in the Phase 2 TORREY study. Nevertheless, investors dumped the stock - due to Seralutinib's perceived inferiority to Merck's Sotatercept. On a 6-minut...

United Therapeutics (Nasdaq: UTHR ), a public benefit corporation, today announced that the company has been named on Newsweek’s list of America’s Most Responsible Companies 2023. This award is presented by Newsweek and Statista Inc., the world-leading statistics portal and indu...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips You’ll often hear people say that bear markets are great for finding bargains, and that’s true. With the exception of energy, every major sector is in the red for the year. For its part, the iShares Biotechnolo...

United Therapeutics Corporation (UTHR) Q3 2022 Earnings Conference Call November 02, 2022 9:00 AM ET Company Participants Dewey Sedman – Head-Investor Relations Martine Rothblatt – Chairperson and Chief Executive Officer Michael Benkowitz – P...